Insider Trading Alert - ISR, RFP And IDTI Traded By Insiders - TheStreet

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 9, 2015, 89 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $352.00 to $81,483,250.00.

Highlighted Stocks Traded by Insiders:

IsoRay (ISR) - FREE Research Report

Babcock Dwight William, who is Ceo at IsoRay, bought 10,000 shares at $1.53 on June 9, 2015. Following this transaction, the Ceo owned 301,402 shares meaning that the stake was boosted by 3.43% with the 10,000-share transaction.

The shares most recently traded at $1.55, up $0.02, or 1.3% since the insider transaction. Historical insider transactions for IsoRay go as follows:

  • 4-Week # shares bought: 10,000
  • 12-Week # shares bought: 10,000
  • 24-Week # shares bought: 20,029

The average volume for IsoRay has been 3.1 million shares per day over the past 30 days. IsoRay has a market cap of $85.1 million and is part of the health care sector and health services industry. Shares are up 6.16% year-to-date as of the close of trading on Tuesday.

IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. Currently, there is 1 analyst who rates IsoRay a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ISR - FREE

TheStreet Quant Ratings

rates IsoRay as a

sell

. The company's weaknesses can be seen in multiple areas, such as its poor profit margins and generally disappointing historical performance in the stock itself. Get the full

IsoRay Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Resolute Forest Products (RFP) - FREE Research Report

Steelhead Navigator Master, L.P., who is 10% Owner at Resolute Forest Products, sold 2.8 million shares at $11.40 on June 9, 2015. Following this transaction, the 10% Owner owned 8.9 million shares meaning that the stake was reduced by 23.61% with the 2.8 million-share transaction.

The shares most recently traded at $12.38, up $0.98, or 7.92% since the insider transaction. Historical insider transactions for Resolute Forest Products go as follows:

  • 4-Week # shares sold: 223,700
  • 12-Week # shares sold: 223,700
  • 24-Week # shares sold: 444,579

The average volume for Resolute Forest Products has been 394,000 shares per day over the past 30 days. Resolute Forest Products has a market cap of $1.1 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are down 31.23% year-to-date as of the close of trading on Tuesday.

Resolute Forest Products Inc. operates in the forest products industry in the United States, Canada, and South Korea. It operates through four segments: Newsprint, Specialty Papers, Market Pulp, and Wood Products. Currently, there is 1 analyst who rates Resolute Forest Products a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RFP - FREE

TheStreet Quant Ratings

rates Resolute Forest Products as a

hold

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and poor profit margins. Get the full

Resolute Forest Products Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Integrated Device Technology (IDTI) - FREE Research Report

Padval Umesh, who is Director at Integrated Device Technology, sold 2,500 shares at $20.16 on June 9, 2015. Following this transaction, the Director owned 38,477 shares meaning that the stake was reduced by 6.1% with the 2,500-share transaction.

The shares most recently traded at $23.96, up $3.80, or 15.86% since the insider transaction. Historical insider transactions for Integrated Device Technology go as follows:

  • 4-Week # shares bought: 100,000
  • 4-Week # shares sold: 2,340
  • 12-Week # shares bought: 100,000
  • 12-Week # shares sold: 7,340
  • 24-Week # shares bought: 100,000
  • 24-Week # shares sold: 23,635

The average volume for Integrated Device Technology has been 2.9 million shares per day over the past 30 days. Integrated Device Technology has a market cap of $3.5 billion and is part of the technology sector and electronics industry. Shares are up 20.77% year-to-date as of the close of trading on Tuesday.

Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of semiconductor solutions for the communications, computing, and consumer industries worldwide. It operates in two segments, Communications, and Computing and Consumer. The company has a P/E ratio of 38.7. Currently, there are 4 analysts who rate Integrated Device Technology a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on IDTI - FREE

TheStreet Quant Ratings

rates Integrated Device Technology as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Integrated Device Technology Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.